Should Trials Carry a Health Warning?
| dc.date.accessioned | 2016-01-08T19:38:14Z | en |
| dc.date.available | 2016-01-08T19:38:14Z | en |
| dc.date.created | 1991-12-14 | en |
| dc.date.issued | 1991-12-14 | en |
| dc.identifier.bibliographicCitation | LANCET 1991 December 14; 338(8781): 1495-1496 | en |
| dc.identifier.uri | http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Should+Trials+Carry+a+Health+Warning?&title=LANCET+&volume=338&issue=8781&spage=1495-1496&date=1991-12&au= | en |
| dc.identifier.uri | http://hdl.handle.net/10822/851204 | en |
| dc.format | Article | en |
| dc.language | en | en |
| dc.source | eweb:112422 | en |
| dc.subject | Health | en |
| dc.subject.classification | Informed Consent or Human Experimentation | en |
| dc.title | Should Trials Carry a Health Warning? | en |
| dc.provenance | Citation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database. | en |
| dc.provenance | Citation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown. | en |
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Registration of Drugs for Treating Cancer and HIV Infection: A Plea to Carry Out Phase 3 Trials Before Admission to the Market
(1995-05-20)Drugs for cancer and HIV infection tend to be admitted to the market on the basis of results from phase 2 trials. Assessing the benefit-risk balance with phase 2 trials often is difficult -- the effect of the drug is usually ...